Follow
Oncology Venture AS
Nasdaq First North Sweden (Sweden)
Oncology Venture AS is engaged in the development of anticancer medicines. The company's current priority program focus is on the advancement of three precision medicine treatments: 2X-121, Dovitinib and Ixempra targeting the market for the treatment of ovarian cancer, breast cancer, and renal cell carcinoma. The company holds the rights to develop four additional precision medicine programs: LiPlaCis, Irofulven, APO010 and 2X-111.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
OV
DK0060732477
Nasdaq First North Sweden
Sweden (SE)
Details of share in Oncology Venture AS with ticker OV
Status
Active
Order book id
Amount of instruments
169 240 983
Par value
0.0500
Market cap
Currency
SEK
Segment
First North
First trading date
22 Jul 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.40 SEK
32.5M SEK
05 Jun - 24 Jun 2015
IPO in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
10.00 SEK
72.3M SEK
12 May - 26 May 2016
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
29.00 SEK
269.7M SEK
27 Oct - 10 Nov 2016
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
42.00 SEK
423.1M SEK
16 Mar - 30 Mar 2017
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.30 SEK
178.8M SEK
11 Jan - 25 Jan 2018
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Market move
31 Aug 2018
Listing of Oncology Venture AS on Nasdaq First North Sweden
Type
Price
Pre-money valuation
Time
Files
Rights issue
4.00 SEK
201.2M SEK
17 Apr - 02 May 2019
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
01 Jun - 07 Jun 2019
01 Sep - 06 Sep 2019
01 Dec - 06 Dec 2019
Option exercise terms for OV TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
140M SEK
31 Oct - 21 Nov 2019
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
2.20 SEK
6.07M DKK
10 Jan 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
2.00 SEK
24 Feb 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
New issue
1.77 SEK
07 May 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
202M SEK
09 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
263.14M SEK
10 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.4968 SEK
231.38M SEK
18 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.27 SEK
268.94M SEK
30 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.52 SEK
241.68M SEK
13 Jul 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
241.68M SEK
14 Jul 2020
Share issue in Oncology Venture AS
Type
Ticker
ISIN
Market
OPTION
OV TO 2
DK0061153657
Nasdaq First North Sweden
Sweden (SE)
Details of option in Oncology Venture AS with ticker OV TO 2
Status
Active
Order book id
Amount of instruments
50 341 080
Market cap
Currency
SEK
Trading period
04 Feb 2020 - 13 Sep 2021
Terms
One (1) warrant gives the right to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
01 Apr - 15 Apr 2020
01 Sep - 15 Sep 2020
01 Feb - 15 Feb 2021
01 May - 15 May 2021
01 Sep - 15 Sep 2021
Option exercise terms for OV TO 2
Type
Ticker
ISIN
Market
SHARE
OV
SE0007157409
Spotlight
Sweden (SE)
Details of share in Oncology Venture AS with ticker OV
Status
Archived
Order book id
Amount of instruments
Par value
Market cap
Currency
SEK
First trading date
22 Jul 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.40 SEK
32.5M SEK
05 Jun - 24 Jun 2015
IPO in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
10.00 SEK
72.3M SEK
12 May - 26 May 2016
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
29.00 SEK
269.7M SEK
27 Oct - 10 Nov 2016
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
42.00 SEK
423.1M SEK
16 Mar - 30 Mar 2017
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.30 SEK
178.8M SEK
11 Jan - 25 Jan 2018
Share issue in Oncology Venture AS
Type
Ticker
ISIN
Market
SHARE
OV
DK0060732477
Nasdaq First North Sweden
Sweden (SE)
Details of share in Oncology Venture AS with ticker OV
Status
Active
Order book id
Amount of instruments
169 240 983
Par value
0.0500
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Files
Market move
31 Aug 2018
Listing of Oncology Venture AS on Nasdaq First North Sweden
Type
Price
Pre-money valuation
Time
Files
Rights issue
4.00 SEK
201.2M SEK
17 Apr - 02 May 2019
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
140M SEK
31 Oct - 21 Nov 2019
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
2.20 SEK
6.07M DKK
10 Jan 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
2.00 SEK
24 Feb 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
New issue
1.77 SEK
07 May 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
202M SEK
09 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
263.14M SEK
10 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.4968 SEK
231.38M SEK
18 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.27 SEK
268.94M SEK
30 Jun 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.52 SEK
241.68M SEK
13 Jul 2020
Share issue in Oncology Venture AS
Type
Price
Pre-money valuation
Time
Files
Directed issue
1.33 SEK
241.68M SEK
14 Jul 2020
Share issue in Oncology Venture AS
Type
Ticker
ISIN
Market
OPTION
OV TO 1
DK0061139581
Nasdaq First North Sweden
Sweden (SE)
Details of option in Oncology Venture AS with ticker OV TO 1
Status
Archived
Order book id
176918
Amount of instruments
20 166 221
Market cap
Currency
SEK
Trading period
24 Jul 2019 - 22 May 2020
Terms
One (1) Investor Warrant confers the right to subscribe one (1) Additional Share of nominal DKK 0.05 in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
01 Jun - 07 Jun 2019
01 Sep - 06 Sep 2019
01 Dec - 06 Dec 2019
Option exercise terms for OV TO 1
Type
Ticker
ISIN
Market
OPTION
OV TO 2
DK0061153657
Nasdaq First North Sweden
Sweden (SE)
Details of option in Oncology Venture AS with ticker OV TO 2
Status
Active
Order book id
Amount of instruments
50 341 080
Market cap
Currency
SEK
Trading period
04 Feb 2020 - 13 Sep 2021
Terms
One (1) warrant gives the right to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
01 Apr - 15 Apr 2020
01 Sep - 15 Sep 2020
01 Feb - 15 Feb 2021
01 May - 15 May 2021
01 Sep - 15 Sep 2021
Option exercise terms for OV TO 2
People
Number of Employees
16 people
Peter Buhl Jensen
CEO
Frank Knudsen
Chairman of the board
Peter Buhl Jensen
Board member
Frank Knudsen
Board member
Gunnar Magnus Severus Modée Persson
Board member
Steen Meier Knudsen
Board member
Niels Johansen
Board member
Company Details
Sector
HEALTH CARE

Address
VENLIGHEDSVEJ 1
Zip code
2970
City/district
HØRSHOLM
Country
Denmark (DK)
Registration number
28106351
LEI code
213800FKAPK1MPJ18Q79
First trade date
22 Jul 2015
Company former names
Medical Prognosis Institute A/S
03 Sep 2018
Registration date
09 Sep 2004
Short name
Oncology Venture

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date